1. Home
  2. RPHM vs VIVK Comparison

RPHM vs VIVK Comparison

Compare RPHM & VIVK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RPHM
  • VIVK
  • Stock Information
  • Founded
  • RPHM 2014
  • VIVK 2006
  • Country
  • RPHM United States
  • VIVK United States
  • Employees
  • RPHM N/A
  • VIVK N/A
  • Industry
  • RPHM Biotechnology: Pharmaceutical Preparations
  • VIVK Oilfield Services/Equipment
  • Sector
  • RPHM Health Care
  • VIVK Energy
  • Exchange
  • RPHM Nasdaq
  • VIVK Nasdaq
  • Market Cap
  • RPHM 47.5M
  • VIVK 43.9M
  • IPO Year
  • RPHM 2021
  • VIVK N/A
  • Fundamental
  • Price
  • RPHM N/A
  • VIVK $1.49
  • Analyst Decision
  • RPHM Hold
  • VIVK
  • Analyst Count
  • RPHM 6
  • VIVK 0
  • Target Price
  • RPHM $2.26
  • VIVK N/A
  • AVG Volume (30 Days)
  • RPHM 345.4K
  • VIVK 90.3K
  • Earning Date
  • RPHM 11-11-2024
  • VIVK 11-18-2024
  • Dividend Yield
  • RPHM N/A
  • VIVK N/A
  • EPS Growth
  • RPHM N/A
  • VIVK N/A
  • EPS
  • RPHM N/A
  • VIVK N/A
  • Revenue
  • RPHM N/A
  • VIVK $62,388,755.00
  • Revenue This Year
  • RPHM N/A
  • VIVK N/A
  • Revenue Next Year
  • RPHM N/A
  • VIVK N/A
  • P/E Ratio
  • RPHM N/A
  • VIVK N/A
  • Revenue Growth
  • RPHM N/A
  • VIVK 8.99
  • 52 Week Low
  • RPHM $1.68
  • VIVK $0.44
  • 52 Week High
  • RPHM $92.10
  • VIVK $3.45
  • Technical
  • Relative Strength Index (RSI)
  • RPHM 18.64
  • VIVK 41.85
  • Support Level
  • RPHM $16.10
  • VIVK $1.43
  • Resistance Level
  • RPHM $19.00
  • VIVK $1.69
  • Average True Range (ATR)
  • RPHM 1.09
  • VIVK 0.20
  • MACD
  • RPHM -1.48
  • VIVK 0.00
  • Stochastic Oscillator
  • RPHM 0.00
  • VIVK 19.30

About RPHM Reneo Pharmaceuticals Inc.

Reneo Pharmaceuticals Inc is a clinical-stage pharmaceutical company. It is focused on the development of therapies for patients with rare genetic mitochondrial diseases, which are often associated with the inability of mitochondria to produce adenosine triphosphate (ATP). The company is developing REN001 to modulate genes critical to metabolism and generation of ATP, which is the primary source of energy for cellular processes.

About VIVK Vivakor Inc.

Vivakor Inc is a socially responsible operator, acquirer and developer of technologies and assets in the oil and gas industry, as well as related environmental solutions. It is primarily focused on operating crude oil gathering, storage and transportation facilities, as well as contaminated soil remediation services.

Share on Social Networks: